Trial · NCT05682326
Results by group943
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 943
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Participants Requiring Dialysis (D) | Any AEs | 2 | Participants | |
| Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Participants Not Yet Requiring Dialysis (ND) | Any AEs | 2 | Participants | |
| Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Participants Requiring Dialysis (D) | Any SAEs | 1 | Participants | |
| Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Participants Not Yet Requiring Dialysis (ND) | Any SAEs | 0 | Participants | |
| Number of Participants With Adverse Event of Special Interests (AESIs) | Participants Requiring Dialysis (D) | 0 | Participants | ||
| Number of Participants With Adverse Event of Special Interests (AESIs) | Participants Not Yet Requiring Dialysis (ND) | 0 | Participants | ||
| Number of Participants With AEs Leading to Study Intervention Discontinuation | Participants Requiring Dialysis (D) | 0 | Participants | ||
| Number of Participants With AEs Leading to Study Intervention Discontinuation | Participants Not Yet Requiring Dialysis (ND) | 0 | Participants | ||
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 4 | 0.0160 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 4 | 0.0030 | Standard Deviation 0.03818 | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 8 | 0.0530 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 8 | 0.0025 | Standard Deviation 0.03889 | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 12 | -0.0280 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 12 | 0.0135 | Standard Deviation 0.01485 | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 16 | -0.0200 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 16 | -0.0185 | Standard Deviation 0.03889 | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 20 | 0.0000 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 20 | -0.0005 | Standard Deviation 0.01909 | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Requiring Dialysis (D) | Week 24 | 0.0050 | Standard Deviation NA | Percentage of red blood cells in blood |
| Change From Baseline in Hematology Parameter: Hematocrit | Participants Not Yet Requiring Dialysis (ND) | Week 24 | 0.0060 | Standard Deviation 0.02687 | Percentage of red blood cells in blood |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05682326/results